| PrednisoLONE Sodium Phosphate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| PrednisoLONE Sodium Phosphate sodium phosphate 20 mg/mL | solution | injectable | 1.0 milliliter(s) | OTC |
| PrednisoLONE Sodium Phosphate sodium phosphate 15 mg/5 mL | liquid | oral | 5.0 milliliter(s) | OTC |
| PrednisoLONE Sodium Phosphate sodium phosphate 5 mg/5 mL | liquid | oral | 5.0 milliliter(s) | OTC |
| PrednisoLONE Sodium Phosphate sodium phosphate | powder | compounding | 100.0 gram(s) | OTC |
biomarin Announces Third Quarter 2007 Financial Results - PR Newswire (press release)
... including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ...
Thu Nov 01 14:15:20 -0400 2007
biomarin Announces Third Quarter 2007 Financial Results - CNNMoney.com
... including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ...
Thu Nov 01 13:06:46 -0400 2007
prednisolone sodium phosphate - The sodium phosphate salt form of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. As a glucocorticoid receptor agonist, prednisolone sodium phosphate binds to specific intracellular glucocorticoid receptors, and causes the ligand- receptor complex to be translocated to the nucleus where it initiates the transcription of glucocorticoid-responsive genes such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.
prednisolone (as sodium phosphate)